Epidemiology of Hepatitis C Virus Infection Among 1,959 Patients in Shiraz, Southern Iran, Between 1991 and 2016

被引:1
|
作者
Babaei, Amir Hossein [1 ,2 ]
Safarpour, Ali Reza [3 ]
Fattahi, Mohammad Reza [3 ]
Ahmadi, Vida [3 ]
机构
[1] Shiraz Univ Med Sci, Student Res Comm, Shiraz, Iran
[2] Shiraz Univ Med Sci, Dept Otolaryngol, Shiraz, Iran
[3] Shiraz Univ Med Sci, Gastroenterohepatol Res Ctr, Shiraz, Iran
来源
关键词
Hepacivirus; Risk Factor; Genotype; Substance Abuse; Blood Transfusion; GLOBAL DISTRIBUTION; MIDDLE-EAST; PREVALENCE; GENOTYPES; BURDEN;
D O I
10.5812/archcid.98849
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Hepatitis C virus (HCV) infection is an important public health hazard, with approximately 71 million chronically HCV-infected individuals around the world. Objectives: This study was designed to provide epidemiologic information on HCV, evaluate the possible route of transmission and its associated risk factors, and characterize the prevalence and distribution of HCV genotypes among HCV-infected patients in Fars Province, Southern Iran. Methods: This cross-sectional descriptive-analytical study was performed with the medical records of patients with HCV infection who had referred to the Gastroenterohepatology Research Center, Shiraz, Iran. The extracted data had been gathered from 1991 to 2016. The data included the time of diagnosis, demographic information, information on the course of the disease (including symptoms at disease onset), history of exposure to possible routes of transmission, risk factors, HCV genotype (if available), and family history of HCV infection. The relationship between two categorical variables was determined using the chi-square or Fisher's exact tests. The relationship between categorical and quantitative variables was tested by one-way ANOVA. The Kendall-tau test was used to show the changing trends of risk factors regarding age and year groups. Univariate analysis was done and odds ratios were calculated to determine the relationship between genotypes and possible routes of HCV transmission. Results: From the total of 1,959 patients, 1,748 (88.20%) were males. An analysis of the trend of possible risk factors showed that the prevalence of cupping, intravenous drug use (IVDU), non-intravenous drug use (non-IVDU), penetrating trauma, tattooing, and high-risk sexual behaviors significantly increased over the study period. A significant reduction was observed in the rate of major thalassemia. The most prevalent HCV genotype was genotype 1(49.3%), followed by genotype 3 (39.6%). Multivariate analysis of the possible routes of transmission revealed that cupping was associated with the increased risk of HCV genotype 1 infection. Conclusions: This study reports non-IVDU as the most common associated risk factor and genotype 1 as the most prevalent genotype in patients infected with HCV. Knowing risk factors can lead to making better policies and implement more effective interventions to prevent the spread of HCV infection.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Determinants of stigma among patients with hepatitis C virus infection
    Saine, M. Elle
    Szymczak, Julia E.
    Moore, Tyler M.
    Bamford, Laura P.
    Barg, Frances K.
    Schnittker, Jason
    Holmes, John H.
    Mitra, Nandita
    Lo Re, Vincent, III
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (11) : 1179 - 1189
  • [32] Psoriasis frequency among patients with hepatitis C virus infection
    Allegue Gallego, Fernando Javier
    Garcia Simon, Maria Sergia
    Sanchez Martinez, Inmaculada
    Robles Garcia, Isabel Susana
    Pardo Sanchez, Jose
    Alarcon Sodevilla, Fernando
    Ruffin Villaoslada, Luis Javier
    Abbad Asensio, Luis Enrique
    Lopez Avila, Angel
    Mira Sirvent, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB260 - AB260
  • [33] Occult Hepatitis C Virus Infection among Hemodialysis Patients
    Barril, Guillermina
    Castillo, Inmaculada
    Dolores Arenas, Maria
    Espinosa, Mario
    Garcia-Valdecasas, Juan
    Garcia-Fernandez, Nuria
    Gonzalez-Parra, Emilio
    Maria Alcazar, Jose
    Sanchez, Carmen
    Carlos Diez-Baylon, Jose
    Martinez, Pilar
    Bartolome, Javier
    Carreno, Vicente
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 19 (12): : 2288 - 2292
  • [34] Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan
    Chang, CJ
    Ko, YC
    Liu, HW
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1998, 97 (12) : 826 - 829
  • [35] Seroprevalence of hepatitis B virus among hemodialysis patients in Bushehr province, southern Iran
    Mostaghni, Amir Ahmad
    Soltanian, Alireza
    Mokhtari, Elaheh
    Japoni, Sara
    Mehrabani, Davood
    HEPATITIS MONTHLY, 2011, 11 (03) : 200 - 202
  • [36] Molecular based epidemiology of SEN virus infection among hepatitis B and hepatitis C patients in YanBian City, China.
    Okayama, S
    Mikuni, M
    Matsumura, H
    Aoki, H
    Oshiro, S
    Watanabe, A
    Arakawa, Y
    Nakamura, H
    Moriyama, M
    Tanaka, N
    Arakawa, Y
    HEPATOLOGY, 2001, 34 (04) : 637A - 637A
  • [37] Hepatitis B, C virus co-infection and behavioral risks in HIV-positive patients in southern Iran
    Zahedi, Mohammad Javad
    Moghaddam, Sodaif Darvish
    Abasi, Mehdi Hayatbakhsh
    Parnian, Maryam
    Shokoohi, Mostafa
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2014, 64 (02) : 134 - 137
  • [38] The Prevalence of Hepatitis C Virus Infection and Its Related Risk Factors Among the Rural Population of Fars Province, Southern Iran
    Fattahi, Mohammad Reza
    Safarpour, Alireza
    Sepehrimanesh, Masood
    Mohammad, Seyed
    Asl, Kazem Hosseini
    Mohamaddoust, Faezeh
    HEPATITIS MONTHLY, 2015, 15 (02)
  • [39] Epidemiology and natural history of hepatitis C virus infection among children and young people
    Modin, Line
    Arshad, Adam
    Wilkes, Bryony
    Benselin, Jennifer
    Lloyd, Carla
    Irving, William L.
    Kelly, Deirdre A.
    JOURNAL OF HEPATOLOGY, 2019, 70 (03) : 371 - 378
  • [40] Association Between ACOX1 and NRF1 Gene Expression and Hepatitis B and C Virus Infections and Hepatocellular Carcinoma in Liver Transplant Patients (Shiraz, Iran)
    Abdolyousefi, Ehsan Nabi
    Motalleb, Gholamreza
    Yaghobi, Ramin
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2022, 20 (01)